Content Type: Article

  • Transgender Health Benefits: Best Practices and Legal Considerations

    ARTICLE

    Transgender Health Benefits: Best Practices and Legal Considerations

    August 2019

    Read time: 2 min

    Key takeaways
    Overview

    Todd Solomon, Jacob Mattinson and Erin Steele authored this bylined article about how the decision to provide or exclude gender transition-related medical coverage impacts legal compliance, overall costs and workplace culture.

    In depth
    Authors

    Todd A. Solomon

    Partner

    Chicago

    Jacob M. Mattinson

    Partner

    Chicago

    More insights

  • Federal Court Dismisses Challenge to ESOP Transaction

    Federal Court Dismisses Challenge to ESOP Transaction

    ARTICLE / CLIENT ALERT

    Federal Court Dismisses Challenge to ESOP Transaction

    August 12, 2019

    Read time: 4 min

    Key takeaways
    Overview

    In Lee v. Argent Trust Co., the court dismissed ERISA claims challenging an ESOP stock transaction because the plaintiff, who “fundamentally misunderstands the nature of the” ESOP transaction, did not allege that she suffered any injury. This decision is important to educate other courts about economics, particularly in cases where plaintiffs rely on little more than the post-transaction valuation as evidence of supposed overvaluation.

    In depth

    On August 7, 2019, a district court dismissed ERISA claims against a trustee, sponsor company and individuals because the complaint did not plead that the ESOP transaction was overvalued. The claims related to the Choate Construction Company ESOP. Choate is a privately held company that formed an ESOP in 2016. It retained Argent as the plan’s trustee, and Argent was responsible for evaluating and overseeing the initial ESOP stock purchase.

    In December 2016, the ESOP bought 8 million shares, or 80% of Choate’s stock, for $198 million as part of a leveraged transaction. Like many ESOP transactions, the Choate ESOP’s stock purchase was financed with a $57 million loan that Choate borrowed from a bank and then loaned to the ESOP. To finance the remainder, the ESOP issued notes to the selling shareholders for the remaining $141 million.

    The plaintiff, a former employee, filed a class action under ERISA alleging that the ESOP purchase was overvalued. The complaint relied principally on the valuation right after the transaction at year-end 2016, less than a month after the ESOP deal. The plaintiff alleged that the company, allegedly worth $198 million at the time of the transaction, was worth only $68.4 million after the transaction.

    The defendants moved to dismiss for lack of subject-matter jurisdiction and for failure to state a claim. Focusing on the subject-matter jurisdiction question, the court noted that federal courts have jurisdiction only if a plaintiff suffers an injury related to the alleged misconduct. A plaintiff uninjured by alleged misconduct has no standing to sue. The court determined that the plaintiff failed to allege injury because she “fundamentally misunderstands” the nature of the leveraged ESOP transaction. The court viewed the transaction like a house purchase, giving the following example: suppose a buyer with no money for a down-payment has to borrow against a house she purchases for $198,000. After the purchase, the buyer’s equity is zero, assuming the house is actually worth $198,000. But what if the house were worth $262,000, and not $198,000? Right after the transaction, the buyer, who put up no money, now has $64,800 in equity.

    The ESOP transaction was similar. The ESOP’s year-end valuation in 2016 was $64.8 million, meaning that the ESOP immediately after the transaction had $64.8 million in equity and realized “an immediate economic benefit.” This allegation undercut the plaintiff’s claims of an overvalued transaction. The plaintiff did not plead that she suffered any injury, and thus lacked Article III standing to sue.

    McDermott Viewpoint

    Plaintiffs often allege that post-transaction valuations evidence an inflated price at the time of an ESOP stock transaction. This court correctly understood the economics of a leveraged ESOP transaction, namely that taking on debt reduces equity value and is not evidence of an overvaluation. This decision is important to educate other courts about these economics, particularly in cases where plaintiffs rely on little more than the post-transaction valuation as evidence of supposed overvaluation.

    Authors

    J. Christian Nemeth

    Partner

    Chicago, Miami

    More insights

  • The AI Hype: Separating Fact from Fiction

    ARTICLE

    The AI Hype: Separating Fact from Fiction

    August 12, 2019

    Read time: 2 min

    Key takeaways
    Overview

    Dale Van Demark authored this bylined articled discussing AI tools and solutions available in healthcare and the importance of grounding expectations for this technology in the reality of the industry.

    In depth
    Authors
    More insights

  • New York State Passes a Host of New Employment Laws

    New York State Passes a Host of New Employment Laws

    ARTICLE / CLIENT ALERT

    New York State Passes a Host of New Employment Laws

    August 12, 2019

    Read time: 5 min

    Key takeaways
    Overview

    New York State Outlaws Hairstyle Discrimination

    On July 12, 2019, Governor Cuomo signed a bill amending New York State’s Human Rights and Education Laws to clarify that discrimination based on an individual’s hairstyle is considered race discrimination. The new law, which went into effect immediately, added two new subsections to the Human Rights Law and the Education Law that define the terms “race” and “protective hairstyles” as follows:[1]

    • “race shall . . . include traits historically associated with race, including but not limited to, hair texture and protective hairstyles”; and
    • “protective hairstyles shall include, but not be limited to, such hairstyles as braids, locks and twists.”

    The changes to the Education Law do not apply to private, religious or denominational educational institutions.

    New York City had previously clarified that discrimination on the basis of hairstyle is race discrimination in guidance issued by the New York City Human Rights Commission in February 2019. See client alert, New York City Issues New Guidance on Racial Discrimination on the Basis of Hair.

    Employers should confirm that any grooming or hairstyle policies that they have in place with regard to employees are set forth in facially neutral terms and do not unduly burden or single out individuals of any race.

    New York State Enacts New Pay Equity Laws

    Governor Cuomo recently signed into law two bills that will affect how employers pay their employees. One prohibits employers from asking and relying on salary histories in hiring and the other extends the state’s equal pay law to all protected categories.

    Salary History Inquires

    The state’s new law prohibiting salary history inquiries is similar to New York City’s existing law. See client alert, New York City to Ban Employer Inquiries and Reliance on Salary History. The state’s law will go into effect on Jan. 6, 2020.

    Under the new state law, employers may not consider salary history when deciding whether to hire an applicant and determining the applicant’s salary. The new law also forbids employers from asking current employees or their past employers for the employee’s salary history. Employers are prohibited from taking adverse action against an applicant or an employee for either refusing to disclose salary history or reporting a violation of the law.

    The state’s law includes some exceptions. As with the city’s law, the state’s law does not prevent an applicant or current employee from voluntarily, and without prompting, disclosing or verifying pervious salary history. Further, an employer may confirm an applicant’s or current employee’s salary if at the time the employer makes an offer of employment with compensation, the applicant or current employee responds to the offer by providing salary history to support a proposed salary that is higher than what the employer offered.

    The new law permits applicants, current employees and former employees to sue for violations of the new law. Potential remedies include injunctive relief and attorney’s fees.

    Equal Pay for Similar Work or Substantially Similar Work

    The state’s other new law goes into effect on Oct. 8, 2019 and broadens protections under New York State’s existing equal pay law. Previously, the equal pay law prohibited unequal pay based on sex; the new law expands the prohibition of unequal pay to any member of a protected class under New York law.

    The new law also modifies the standard from “equal pay for similar work” to “equal pay for similar work or substantially similar work.” Accordingly, under the new law, employers cannot pay employees that belong to a protected class less than employees who do the same or substantially similar work and who are not members of that protected class.

    New York State Broadens Protections for Immigrant Employees

    On July 27, 2019, Governor Cuomo signed a bill into law penalizing employers who threaten, penalize, discriminate or retaliate against immigrant employees. The new law clarifies that threatening, penalizing, discriminating or retaliating includes “threatening to contact or contacting United States immigration authorities or otherwise reporting or threatening to report an employee’s suspected citizenship or immigration status or the suspected citizenship or immigration status of an employee’s family or household member.” The new law goes into effect on Aug. 15, 2019.

    New York State Strengthens Employee Protections Against Discrimination and Harassment

    On Aug. 12, 2019, Governor Cuomo signed a new law strengthening employee protections against harassment and other discriminatory practices in the workplace. See client alert New York Strengthens Employee Protections Against Discrimination and Harassment.


    Authored by Mark E. Brossman, Holly H. Weiss, Scott A. Gold, and Andrew B. Lowy.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Holly H. Weiss

    Retired Partner

    New York – 919 Third Avenue

    Andrew B. Lowy

    Partner

    New York – 919 Third Avenue

    More insights

  • SEC Division of Corporate Finance Issues Second No-Action Letter for a Blockchain Token Issuance

    SEC Division of Corporate Finance Issues Second No-Action Letter for a Blockchain Token Issuance

    ARTICLE / CLIENT ALERT

    SEC Division of Corporate Finance Issues Second No-Action Letter for a Blockchain Token Issuance

    August 12, 2019

    Read time: 8 min

    Key takeaways
    Overview

    The SEC Division of Corporate Finance recently issued a no-action letter to Pocketful of Quarters, confirming that the Division will not recommend any enforcement action if the company sells its blockchain-based tokens without registering them under the Securities Act of 1933 and the Securities and Exchange Act of 1934. This exciting determination is the second issuance of a no-action letter in the rapidly evolving the blockchain space.

    In depth

    On July 25, 2019, the Securities and Exchange Commission (the SEC) Division of Corporate Finance (the Division) issued a no-action letter (the PoQ Letter) to Pocketful of Quarters, Inc. (PoQ), confirming that the Division will not recommend any enforcement action if PoQ sells its blockchain-based cryptographically protected tokens—named Quarters—without registering such tokens under the Securities Act of 1933, as amended (the Securities Act), and the Securities and Exchange Act of 1934 (the Exchange Act. See the PoQ Letter.

    The PoQ no-action letter is the second no-action letter published by the Division with respect to the sale of blockchain-based digital assets or tokens. In April 2019 (in connection with its release of the digital framework), the Division issued a no-action letter (the TKJ Letter) to TurnKey Jet, Inc. (TKJ), advising that no enforcement action against TKJ under the Securities Act or the Exchange Act would be recommended by the Division in connection with the sale of TKY’s blockchain-based tokens. See the TKJ Letter. And please find a link to McDermott’s discussion of the SEC’s digital framework and the TKJ Letter.

    Notably, both the PoQ Letter and the TKJ Letter are responses to proposals to sell and use blockchain tokens to solve a perceived payment systems problem specific to a particular industry. The TKJ tokens, as described to the Division in the letter submitted by TKJ (the TKJ Submission), are intended to streamline the mechanics of payment settlement for air charter services by allowing consumers to pre-purchase tokens that can be redeemed only to charter air transportation, thereby eliminating risks related to delays in payment or charge backs often associated with large financial transactions. PoQ’s Quarters, as described to the Division in the letter submitted by PoQ (the PoQ Submission), are intended to operate as a mechanism for the video game industry to allow those who play video games to transfer in-game purchased value across video game platforms. This would prevent the loss of gaming credits, coins or other units of account purchased or earned while playing video games.

    As described to the SEC in the PoQ Submission, PoQ will offer an unlimited supply of Quarters to consumers at a fixed price. Quarters will not be tradable on a secondary market. As a result, according to the PoQ Submission, price appreciation for Quarters will not be possible. PoQ expects Quarters to be sold, or in some circumstances awarded, to gamers, who will only be able to use the Quarters for playing video games. The proceeds of the sale of Quarters, as explained in the PoQ Submission, will be invested in Ether via smart contracts. PoQ will assign designated wallets to video game developers and those who promote video games, described as influencers in the POQ Submission. The developers will be authorized by PoQ to exchange for Ether the Quarters that have been earned on their video games from game players and transferred to the specially designated wallets. Similarly, influencers who successfully market the use of Quarters by video game consumers will be awarded Quarters by PoQ.

    “The Quarters Platform relies on blockchain technology to provide transparency and security,” PoQ’s lawyers wrote in the PoQ Submission. “The ability for all parties—games, [d]evelopers and [i]nfluencers— to view and audit all transactions is critical to gain the trust needed for large-scale adoption of a new gaming token accepted for use in multiple otherwise unrelated games.”

    Critically, according to the PoQ Submission, video game players will have no ability to exchange their Quarters for Ether or any other digital asset. PoQ represented to the Division in the PoQ Submission that its sale documentation will state: “[b]y design, Quarters are not redeemable for [Ether] from the Quarters [s]mart [c]ontract by gamers and have no financial value for anyone other than [d]evelopers or [i]nfluencers with [a]pproved [a]ccounts.”

    In arguing that Quarters are not securities, the PoQ Submission stated:

    [N]o gamer, Developer or Influencer interacting with the Quarters Platform will reasonably expect any profit from purchasing or holding Quarters; rather gamers that purchase Quarters will simply use them for their consumptive purpose. Likewise, Developers and influencers will seek to acquire Quarters solely as payment for the Services they provide in connection with gameplay on the Quarters Platform. “[W]hen a purchaser is motivated by a desire to use or consume the item purchased,” rather than “the prospects of a return on investment… the securities laws do not apply.” United Housing Foundation, Inc. v. Forman, 421 U.S. 837, at 853-54 (1975)(citing to SEC v. Howey, 328 U.S. 293, 300 (1946))… Gamers will not be able to transfer Quarters to other addresses. Influencers will be prohibited from transferring Quarters other than to the Quarters Smart Contract in exchange for [Ether]. Developers will be prohibited from transferring Quarters other than in connection with Gamer Rewards and transfers to the Quarters Smart Contract in exchange for [Ether]. This will prevent Quarters from trading on a peer-to-peer basis or on any exchanges, preventing a secondary market for Quarters from developing, and eliminating any potential for financial gain as a result of reselling at a price higher than that paid for the Quarters. Accordingly, there is no profit potential under Howey. See PoQ Submission at 12.

    We note that the PoQ Submission referenced a separate blockchain token, the Q2 Tokens, which will available on PoQ’s platform. The holders of Q2 Tokens, according to the PoQ Submission, will receive 15% of the proceeds from the sale of Quarters. The PoQ Submission took the position that Q2 Tokens are securities.

    The Division’s conclusions in each of the PoQ Letter and the TKJ Letter are premised on several common assumptions regarding the purpose, functionality and marketing of the tokens:

    1. The token platform will be operational at the time the tokens are sold and the proceeds of the sale of the tokens will not be used to develop the token platform.
    2. The tokens will be immediately and continuously available to consumers for their intended use.
    3. The tokens will not be able to be transferred outside of the platform created by, respectively, PoQ or TKJ (the tokens cannot be traded on an exchange).
    4. The price of the tokens will not be expected to fluctuate.
    5. The tokens will only be marketed as a means of consuming, respectively, video game or air-charter services.

    The presence of these common assumptions indicate, as we suggested in April, that the Division’s operative policy is that the sale of virtual currencies that cannot be sold for a profit and that can only be used to purchase goods or services on an existing platform does not constitute an investment contract under the Supreme Court’s Howey test and, therefore, the sale and marketing of such virtual currencies are not subject to regulation under the Securities Act or the Exchange Act. See SEC v. Howey, 328 U.S. 293 (1946).

    Under the Howey test, an investment contract exists where there is (1) an investment of money, (2) in a common enterprise (3) with a reasonable expectation of profits to be derived from the efforts of others. As argued in both the PoQ Submission and the TKJ Submission, the absence of an ability of consumers to realize a profit, and the expectation that the token can only be used to consume a service, prevents the third requirement of the Howey test— the existence of a reasonable expectation of profits to be derived from the efforts of others—from being met. This analysis is supported by SEC no-action letters, going back over 30 years, related to other kinds of prepaid services, such as prepaid tuition and prepaid funeral services. See Tuition Plan Consortium, LLP (February 4, 2003); Fleet National Bank (September 5, 1990); Michigan Funeral Directors Association (September 28, 1987).

    The Division’s determination as to PoQ’s Quarters is helpful in that it provides another example of the application of the Howey test by the Division in the blockchain space. However, POQ’s reliance on the absence of an expectation of profit as the dispositive factor in reaching a determination that the sale of Quarters does not constitute an investment contract operates to limit the utility of the PoQ Letter for the majority of participants in the blockchain token industry.

    To date, Bitcoin and Ether have avoided being characterized by the SEC as securities because the markets in which they are traded and the mechanisms with which they are used to settle transactions are sufficiently decentralized as to avoid being part of a common enterprise. Indeed, most users of Bitcoin and Ether openly participate in the market for these assets with an expectation of profit. See Digital Asset Transactions: When Howey Met Gary, William Hinman, Director, Division of Corporation Finance, Remarks at the Yahoo Finance All Markets Summit: Crypto (June 14, 2018).

    It remains unclear whether the Division can be presented with facts under which it will issue a no-action letter for a new blockchain token where profits by purchasers are expected.

    Authors

    David L. Taub

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • Courts’ Approach to Cyber Insurance Continues to Evolve

    ARTICLE

    Courts’ Approach to Cyber Insurance Continues to Evolve

    Summer 2019

    Read time: 1 min

    Key takeaways
    Overview

    Mark Collins co-authored this bylined article discussing the most noteworthy court decisions surrounding cyber insurance.

    In depth
    Authors
    More insights

  • Implementing the EU-U.S. Privacy Shield

    ARTICLE

    Implementing the EU-U.S. Privacy Shield

    August 2019

    Read time: 2 min

    Key takeaways
    Overview

    Amy Pimentel authored this bylined article providing an overview of the laws surrounding the EU-U.S. Privacy Shield Framework.

    In depth
    Authors

    Amy C. Pimentel

    Partner

    Boston

    More insights

  • Kruse-Western Wins Partial Dismissal in ERISA Lawsuit over $244 Million Stock Sale

    Kruse-Western Wins Partial Dismissal in ERISA Lawsuit over $244 Million Stock Sale

    ARTICLE / CLIENT ALERT

    Kruse-Western Wins Partial Dismissal in ERISA Lawsuit over $244 Million Stock Sale

    August 6, 2019

    Read time: 4 min

    Key takeaways
    Overview

    The federal court affirmed ERISA’s limitations on the types of claims and remedies available under ERISA. This well-reasoned decision affords Congress the deference it deserves by limiting claims and remedies only to those Congress intended to provide in ERISA.

    In depth

    In Zavala v. Kruse-Western, Inc. et al., No. 1:19-cv-00239 (E.D. Cal. July 26, 2019), the federal court dismissed the plaintiff’s ERISA claim for equitable relief against non-fiduciaries and ERISA fiduciary-breach claims against shareholders who sold stock to an ESOP. The case affirms some limitations under ERISA for claims against non-fiduciaries and the scope of fiduciary obligations.

    The complaint was brought by a former Kruse-Western employee and current participant in an ESOP. The ESOP bought Kruse-Western’s outstanding stock, allegedly for almost 10 times its actual value, and the plaintiff sued the trustee and the selling shareholders. The two claims against the selling shareholders alleged that they, in a non-fiduciary capacity as sellers, were subject to equitable remedies for receiving plan assets as a result of a prohibited transaction, and that they, in a fiduciary capacity with the obligation to appoint and remove a trustee for the ESOP, failed to monitor GreatBanc.

    The Court dismissed both claims. The equitable claim, which was brought under ERISA § 502(a)(3), failed because ERISA limits such claims to only those that seek “appropriate equitable relief.” The complaint must contain allegations that the relief sought is equitable, rather than legal, or it will be dismissed. Relying on the Ninth Circuit’s recent decision in Depot, Inc. v. Caring for Montanans, Inc., the court explained that appropriate equitable relief focuses on the particular funds the non-fiduciaries obtained and whether the court can impose some type of equitable remedy on those funds. The plaintiff’s complaint must identify those funds in some manner. Without a means to identify the particular funds, the remedy is not equitable, but legal, and legal relief is not available under ERISA § 502(a)(3). The Court granted the plaintiff leave to amend.

    The Court also dismissed a claim against board members for breaching their fiduciary obligation to appoint and monitor an ESOP trustee. Appointing fiduciaries have a limited obligation to select and retain a qualified fiduciary. The plaintiff’s claims really concerned the stock transaction, and the complaint did not plausibly allege that the defendants exercised control over the ESOP and caused it to buy the Kruse-Western stock. That claim also was dismissed with leave to amend.

    McDermott Thoughts

    In recent years, we have seen many plaintiffs attempt to expand the scope of liability under ERISA. ERISA, which was the product of a decade of legislative drafting, discussion, hearings, studies and revision, contains the exclusive causes of action available for ERISA violations, and Congress carefully drafted the remedies provisions to provide for some remedies and exclude others. Non-fiduciaries generally are not liable for others’ fiduciary breaches, and monitoring fiduciaries have extremely limited roles in the underlying fiduciaries’ actual, day-to-day conduct. This well-reasoned decision affords Congress the deference it deserves by limiting claims and remedies only to those Congress intended to provide in ERISA. This limitation protects non-fiduciaries from being held liable for what ultimately are fiduciary obligations under ERISA.

    Authors
    More insights

  • Courts’ Approach to Cyber Insurance Continues to Evolve

    ARTICLE

    Courts’ Approach to Cyber Insurance Continues to Evolve

    August 5, 2019

    Read time: 2 min

    Key takeaways
    Overview

    Mark Collins co-authored this bylined article discussing recent court decisions resolving disputes over insurance coverage for data breaches and other types of costly cyber incidents.

    In depth
    Authors
    More insights

  • Proposed OPPS Changes for 2020: A Review of Four Key Proposals

    Proposed OPPS Changes for 2020: A Review of Four Key Proposals

    ARTICLE / CLIENT ALERT

    Proposed OPPS Changes for 2020: A Review of Four Key Proposals

    August 5, 2019

    Read time: 9 min

    Key takeaways
    Overview

    The Centers for Medicare and Medicaid Services has released proposed updates to payment rates and regulations applicable to the Hospital Outpatient Prospective Payment System for Calendar Year 2020, including proposals relating to hospital price transparency, 340B reimbursement cuts, supervision and prior authorization requirements.

    In depth

    On July 29, 2019, the Centers for Medicare and Medicaid Services (CMS) published a proposed rule setting forth potential revisions to the Medicare Hospital Outpatient Prospective Payment System (OPPS), most of which, if finalized, would become effective on January 1, 2020.

    This On the Subject addresses four key components of the proposed rule:

    1. New proposed regulations that would require hospitals to disclose negotiated rates with third-party payers
    2. The proposed extension of reimbursement cuts for 340B drugs through 2020
    3. Reducing the supervision requirement for outpatient hospital therapeutic services from direct supervision to general supervision
    4. Establishing a prior authorization requirement for five categories of procedures. CMS is accepting public comments on both of these proposals

    Comments must be submitted by 5 pm EDT on September 27, 2019.

    Hospital Pricing Transparency 

    The proposed rule’s hospital price transparency proposals follow a June 24, 2019, Executive Order that directed the US Secretary of Health and Human Services (HHS) to issue a proposed rule requiring hospitals to publicly post charges and information based on negotiated rates and for common “shoppable” healthcare items and services. For a discussion of that Executive Order and other key developments that led to the transparency provisions in the proposed rule, please see our On the Subject: Executive Order on Hospital Price Transparency May Prompt Disclosure of Negotiated Prices.

    As noted in that On the Subject, the Patient Protection and Affordable Care Act (ACA) included a provision requiring hospitals to make public a list of their “standard charges for items and services provided by the hospital.” Aspects of the ACA requirements were previously implemented. This proposed rule would utilize this same statutory authority to promulgate an array of new regulations that expand hospital disclosure obligations. The proposed regulations would define “standard charges” as including both “gross charges” (i.e., chargemaster charges, absent any discount) as well as “payer-specific negotiated charges,” and would broadly define a “third-party payer” as any entity that is, by statute, contract, or agreement, legally responsible for payment of a claim for a healthcare item or service. The major hospital lobbies immediately objected to the proposed changes, and are expected to lobby intensely against the rule and possibly challenge the rule in federal court, if finalized.

    Notably, CMS recognized in the proposed rule that, “the impact resulting from the release of negotiated rates is largely unknown,” and that some stakeholders have expressed concerns that requiring disclosure of negotiated prices could increase healthcare costs or result in anticompetitive behaviors. Given concerns raised by stakeholders related to the release of identifiable negotiated charges, CMS is seeking public comment “on whether and how the release of such specific charge information could result in unintended consequences.”

    We have provided below brief overviews of certain technical proposals relating to implementing the requirements:

    Applicability. The requirements would apply to all “hospitals,” which would be defined as institutions that are either licensed as a hospital pursuant to state law, or which are approved by the hospital licensing agency as meeting the standard for such licensing. “Hospitals” would not include Ambulatory Surgery Centers, but they would include hospitals in rural areas, Critical Access Hospitals and hospitals that treat special populations (such as children’s hospitals and State psychiatric hospitals).

    Items and Services. Hospitals must make public a list of their standard charges for “items and services” provided by the hospital, which would include individual items and services as well as “service packages,” which are defined as “an aggregation of individual items and services into a single service with a single charge.”

    Non-Employed Professionals. Items and services provided by physicians and non-physician practitioners who are not employed by the hospital would not be considered “provided by the hospital,” and their charges would not need to be disclosed.

    Requirements for Disclosure. Hospitals would be required to disclose their standard charges in two ways: (1) a single machine-readable file of charges for all hospital items and services; and (2) a consumer-friendly “display” of common “shoppable” services derived from the machine-readable file.

    Requirements for Shoppable Display. The shoppable services display must show payer-specific negotiated charges for the primary shoppable service side-by-side with payer-specific negotiated charges for all ancillary items and services the hospital “customarily” provides as part of or in conjunction with the primary shoppable service (e.g., laboratory, radiology, anesthesia, drugs, services of employed professionals, etc.). The proposed OPPS rule would require hospitals to provide standard charges for at least 300 shoppable services, but the proposed rule identifies 70 specific shoppable services that a hospital would need to include among their 300 shoppable services (if the services are furnished by a hospital).

    Location Requirements. CMS would require both the machine-readable file and consumer-friendly display to be displayed prominently on the internet, and they must be easily accessible, without barriers. “Displayed prominently” would mean that the value and purpose of the webpage and its content is clearly communicated and there is no reliance on breadcrumbs to help with navigation. “Easily accessible” would mean the file is posted on a website that can be accessed with the fewest number of clicks, and “without barriers” would mean the data can be accessed free of charge and without inputting information or registering for access.

    Penalties and Appeals. Hospitals found to be noncompliant with the new regulations’ requirements and that fail to submit or comply with a Corrective Action Plan would be subject to a Civil Monetary Penalty (CMP) of up to $300 per day, with hospitals subject to such CMPs identified on the CMS website.

    340B Reimbursement

    The proposed OPPS rule was published in the midst of ongoing litigation relating to OPPS reimbursement for drugs purchased through the “340B Program.” In December 2018, the US District Court for the District of Columbia concluded that CMS exceeded its authority when it dramatically lowered reimbursement rates for drugs payable under Medicare Part B and purchased through the 340B Program in calendar year 2018. In May 2019, the Court determined that a 2019 rule that extended the rate reduction to non-excepted (i.e., non-grandfathered) off-campus provider-based departments of a hospital also exceeded CMS’s authority and remanded the two rules to CMS to determine an appropriate remedy. In July 2019—prior to CMS proposing a remedy—the Court entered final judgment, allowing the government to cleanly appeal the Court’s decision to the US Court of Appeals for the District of Columbia Circuit. The government filed an appeal on the same day.

    Despite the District Court’s finding, CMS proposes to continue the 2018-2019 payment reductions through 2020 for 340B-acquired drugs. However, in what may be a veiled political “settlement” offer, CMS suggested that it is considering as an alternative a payment rate of Average Sales Price plus 3%, and solicited comments. In support of this suggested payment rate, CMS noted the District Court’s suggestion that adjusting the ASP plus 6% rate downward by up to 2.9% may not be significant enough to fall outside of CMS’s authority. Reducing ASP plus 6% by 2.9% would result in a reimbursement rate of 103%, after rounding.

    Hospital Outpatient Supervision

    CMS has also proposed lowering the generally applicable minimum level of supervision for hospital outpatient therapeutic services from direct supervision to general supervision for services furnished by all hospitals. “Direct supervision” generally means that a physician or non-physician practitioner is immediately available to furnish assistance and direction throughout the performance of a procedure, although it does not require that the physician or non-physician practitioner be present in the room when the procedure is performed.

    While the direct supervision standard currently applies to all hospitals, CMS and Congress have, at different times, implemented an enforcement moratorium on the requirement for Critical Access Hospitals (CAHs) since 2010 and small rural hospitals since 2011. In the 2020 proposed OPPS rule, CMS observed that the moratorium has “created a two-tiered system of supervision requirements … with direct supervision required for most hospital outpatient therapeutic services in most hospital providers, but only general supervision required for most hospital therapeutic services in CAHs and small rural hospitals…”

    CMS noted in the proposed rule that it has not learned of any data or information from CAHs and small rural hospitals indicating that the quality of outpatient therapeutic services has been affected by the direct supervision enforcement moratorium. As a result, CMS proposed in the 2020 OPPS rule to end the “two-tiered system” and establish a general supervision requirement for all hospital outpatient therapeutic services. General supervision generally means that the procedure is furnished under the physician’s overall direction and control.

    Prior Authorization for Certain Hospital Outpatient Services

    The proposed rule would also establish prior authorization requirements as a condition of Medicare payment for five categories of services: blepharoplasty, botulinum toxin injections, panniculectomy, rhinoplasty and vein ablation. CMS selected these particular procedures because they have both therapeutic and cosmetic indications, and utilization of these services has increased rapidly in recent years. CMS questioned whether some procedures submitted as therapeutic may be truly cosmetic, and therefore not covered. CMS noted that its proposed outpatient hospital prior authorization requirements are patterned after the existing prior authorization program for durable medical equipment, prosthetics and supplies (DMEPOS).

    Under the proposed prior authorization program, hospital outpatient departments would be required to submit documentation to show that a service meets applicable Medicare coverage, coding and payment rules, prior to furnishing a service and submitting a claim. Claims that had not received a provisional affirmation would be denied. If a prior-authorization request were to receive a non-affirmation decision, providers could resubmit the prior authorization request with additional documentation. Non-affirmation decisions could not be appealed, but a claim denial resulting from a claim submitted without an affirmation decision could be appealed.

    Notably, CMS is proposing that providers could be exempt from the prior authorization requirement if they were to achieve a prior authorization provisional affirmation threshold of at least 90% during a semiannual assessment. Exempt providers could lose exemption if their rate of non-payable claims becomes higher than 10% during a biannual assessment. The proposed rule and regulations do not clarify the process by which CMS would biannually identify the percentage of non-payable claims for exempt providers that are not submitting prior authorization requests.

    When combined with the prior authorization already in place for DMEPOS, plus the Appropriate Use Criteria program CMS is rolling out in 2020 for certain imaging services, some believe prior authorization-like programs will become increasingly common in fee-for-service Medicare.

    Authors

    Eric Zimmerman

    Partner

    Washington, DC

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    More insights